Cardiac SERCA2A/B: Therapeutic targets for heart failure

European Journal of Pharmacology

Volumn 724, Issue 1, 2014, Pages 1-8

  Shareef, Mohammad Abrar ^a   Anwer, Lucman A ^a   Poizat, Coralie ^b,c  

^a ALFAISAL UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Calcium; Heart failure; Sarco endoplasmic reticulum Ca2+ ATPase; SERCA2a b

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOVIRUS VECTOR; ASTRAGALOSIDE IV; CANDESARTAN; CARVEDILOL; ENALAPRIL; HYDRALAZINE; PHENYLEPHRINE; PLACEBO; RESVERATROL; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2B; UNCLASSIFIED DRUG;

CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; DRUG MECHANISM; DRUG RESPONSE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE DELIVERY SYSTEM; HEART FAILURE; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A GENE; TREATMENT OUTCOME; VIRAL GENE THERAPY;

CALCIUM; HEART FAILURE; SARCO/ENDOPLASMIC RETICULUM CA(2+)-ATPASE; SERCA2A/B;

ANIMALS; GENETIC THERAPY; HEART DISEASES; HUMANS; MYOCARDIUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84891517858     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.12.018     Document Type: Review

References (103)

1. K.B. Andersson, J.A. Birkeland, A.V. Finsen, W.E. Louch, I. Sjaastad, Y. Wang, J. Chen, J.D. Molkentin, K.R. Chien, O.M. Sejersted, and G. Christensen Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene J. Mol. Cell. Cardiol. 47 2009 180 187
2. A. Anwar, G. Taimor, H. Korkusuz, R. Schreckenberg, T. Berndt, Y. Abdallah, H.M. Piper, and K.D. Schluter PKC-independent signal transduction pathways increase SERCA2 expression in adult rat cardiomyocytes J. Mol. Cell. Cardiol. 39 2005 911 919
3. M. Arai, H. Matsui, and M. Periasamy Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure Circ. Res. 74 1994 555 564
4. M. Arai, A. Yoguchi, T. Takizawa, T. Yokoyama, T. Kanda, M. Kurabayashi, and R. Nagai Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription Circ. Res. 86 2000 8 14
5. 2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban Proc. Natl. Acad. Sci. USA 100 2003 5040 5045
6. J.W. Bassani, R.A. Bassani, and D.M. Bers Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms J. Physiol. 476 1994 279 293
7. R. Beeri, M. Chaput, J.L. Guerrero, Y. Kawase, C. Yosefy, S. Abedat, I. Karakikes, C. Morel, A. Tisosky, S. Sullivan, M.D. Handschumacher, D. Gilon, G.J. Vlahakes, R.J. Hajjar, and R.A. Levine Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation. Circulation Heart Fail. 3 2010 627 634
8. M.C. Berman, and S.J. Karlish Interaction of an aromatic dibromoisothiouronium derivative with the Ca(2+)-ATPase of skeletal muscle sarcoplasmic reticulum Biochemistry 42 2003 3556 3566
9. D.M. Bers Cardiac excitation-contraction coupling Nature 415 2002 198 205
10. L.T. Bish, K. Morine, M.M. Sleeper, J. Sanmiguel, D. Wu, G. Gao, J.M. Wilson, and H.L. Sweeney Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat Hum. Gene Ther. 19 2008 1359 1368
11. 2+ATPase of sarcoplasmic reticulum. Expression in developing skeletal muscle J. Biol. Chem. 262 1987 3768 3774
12. C.R. Bridges, K. Gopal, D.E. Holt, C. Yarnall, S. Cole, R.B. Anderson, X. Yin, A. Nelson, B.W. Kozyak, Z. Wang, J. Lesniewski, L.T. Su, D.M. Thesier, H. Sundar, and H.H. Stedman Efficient myocyte gene delivery with complete cardiac surgical isolation in situ J. Thorac. Cardiovasc. Surg. 130 2005 1364
13. C.D. Byrne, R. Olufadi, K.D. Bruce, F.R. Cagampang, and M.H. Ahmed Metabolic disturbances in non-alcoholic fatty liver disease Clin. Sci. (Lond) 116 2009 539 564
14. A.M. Campbell, P.D. Kessler, and D.M. Fambrough The alternative carboxyl termini of avian cardiac and brain sarcoplasmic reticulum/endoplasmic reticulum Ca(2+)-ATPases are on opposite sides of the membrane J. Biol. Chem. 267 1992 9321 9325
15. A.M. Campbell, P.D. Kessler, Y. Sagara, G. Inesi, and D.M. Fambrough Nucleotide sequences of avian cardiac and brain SR/ER Ca(2+)-ATPases and functional comparisons with fast twitch Ca(2+)-ATPase. Calcium affinities and inhibitor effects J. Biol. Chem. 266 1991 16050 16055
16. A. Cittadini, A. Cuocolo, B. Merola, S. Fazio, D. Sabatini, E. Nicolai, A. Colao, S. Longobardi, G. Lombardi, and L. Sacca Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement Am. J. Physiol. 267 1994 E219 225
17. 2+-ATPase Nature 339 1989 476 478
18. D.M. Clarke, T.W. Loo, and D.H. MacLennan Functional consequences of alterations to amino acids located in the nucleotide binding domain of the Ca2(+)-ATPase of sarcoplasmic reticulum J. Biol. Chem. 265 1990 22223 22227
19. S. Dally, E. Corvazier, R. Bredoux, R. Bobe, and J. Enouf Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart J. Mol. Cell. Cardiol. 48 2010 633 644
20. M.J. Davidson, J.M. Jones, S.M. Emani, K.H. Wilson, J. Jaggers, W.J. Koch, and C.A. Milano Cardiac gene delivery with cardiopulmonary bypass Circulation 104 2001 131 133
21. D. de la Bastie, D. Levitsky, L. Rappaport, J.J. Mercadier, F. Marotte, C. Wisnewsky, V. Brovkovich, K. Schwartz, and A.M. Lompre Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat Circ. Res. 66 1990 554 564
22. P. De, S.G. Roy, D. Kar, and A. Bandyopadhyay Excess of glucocorticoid induces myocardial remodeling and alteration of calcium signaling in cardiomyocytes J. Endocrinol. 209 2011 105 114
23. 2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses J. Biol. Chem. 278 2003 47877 47889
24. H. Endo, M. Miura, M. Hirose, J. Takahashi, M. Nakano, Y. Wakayama, Y. Sugai, Y. Kagaya, J. Watanabe, K. Shirato, and H. Shimokawa Reduced inotropic effect of nifekalant in failing hearts in rats J. Pharmacol. Exp. Ther. 318 2006 1102 1107
25. 2+-ATPase modulates cardiac contraction and relaxation Cardiovasc. Res. 57 2003 20 27
26. Y. Fromes, A. Salmon, X. Wang, H. Collin, A. Rouche, A. Hagege, K. Schwartz, and M.Y. Fiszman Gene delivery to the myocardium by intrapericardial injection Gene Ther. 6 1999 683 688
27. P. Gelebart, V. Martin, J. Enouf, and B. Papp Identification of a new SERCA2 splice variant regulated during monocytic differentiation Biochem. Biophys. Res. Commun. 303 2003 676 684
28. J.K. Ghali, W.B. Smith, G. Torre-Amione, W. Haynos, B.K. Rayburn, A. Amato, D. Zhang, D. Cowart, G. Valentini, P. Carminati, and M. Gheorghiade A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function Am. J. Cardiol. 99 2007 47A 56A
29. A.L. Greene, M.J. Lalli, Y. Ji, G.J. Babu, I. Grupp, M. Sussman, and M. Periasamy Overexpression of SERCA2b in the heart leads to an increase in sarcoplasmic reticulum calcium transport function and increased cardiac contractility J. Biol. Chem. 275 2000 24722 24727
30. P.M. Grossman, Z. Han, M. Palasis, J.J. Barry, and R.J. Lederman Incomplete retention after direct myocardial injection Catheter. Cardiovasc. Interv.: Off. J. Soc. Cardiac. Angiogr. Interv. 55 2002 392 397
31. X. Guo, D. Chapman, and N.S. Dhalla Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan Mol. Cell. Biochem. 254 2003 163 172
32. R.J. Guzman, P. Lemarchand, R.G. Crystal, S.E. Epstein, and T. Finkel Efficient and selective adenovirus-mediated gene transfer into vascular neointima Circulation 88 1993 2838 2848
33. J.K. Gwathmey, A.I. Yerevanian, and R.J. Hajjar Cardiac gene therapy with SERCA2a: from bench to bedside J. Mol. Cell. Cardiol. 50 2011 803 812
34. R.J. Hajjar, U. Schmidt, T. Matsui, J.L. Guerrero, K.H. Lee, J.K. Gwathmey, G.W. Dec, M.J. Semigran, and A. Rosenzweig Modulation of ventricular function through gene transfer in vivo Proc. Natl. Acad. Sci. USA 95 1998 5251 5256
35. R.J. Hajjar, K. Zsebo, L. Deckelbaum, C. Thompson, J. Rudy, A. Yaroshinsky, H. Ly, Y. Kawase, K. Wagner, K. Borow, B. Jaski, B. London, B. Greenberg, D.F. Pauly, R. Patten, R. Starling, D. Mancini, and M. Jessup Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure J. Card. Fail. 14 2008 355 367
36. G. Hasenfuss, M. Meyer, W. Schillinger, M. Preuss, B. Pieske, and H. Just Calcium handling proteins in the failing human heart Basic Res. Cardiol. 92 Suppl 1 1997 87 93
37. M. Hayase, F. Del Monte, Y. Kawase, B.D. Macneill, J. McGregor, R. Yoneyama, K. Hoshino, T. Tsuji, A.M. De Grand, J.K. Gwathmey, J.V. Frangioni, and R.J. Hajjar Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade Am. J. Physiol. Heart Circ. Physiol. 288 2005 H2995 3000
38. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation J. Clin. Invest. 100 1997 380 389
39. S.T. Hu, Y. Tang, Y.F. Shen, H.H. Ao, J. Bai, Y.L. Wang, and Y.J. Yang Protective effect of oxymatrine on chronic rat heart failure J. Physiol. Sci. 61 2011 363 372
40. E. Hughes, R. Edwards, and D.A. Middleton Heparin-derived oligosaccharides interact with the phospholamban cytoplasmic domain and stimulate SERCA function Biochem. Biophys. Res. Commun. 401 2010 370 375
41. L.M. Hung, J.K. Chen, S.S. Huang, R.S. Lee, and M.J. Su Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes Cardiovasc. Res. 47 2000 549 555
42. 2+ ATPase (SERCA) inhibition J. Bioenerg. Biomembr. 37 2005 365 368
43. J.M. Isner Myocardial gene therapy Nature 415 2002 234 239
44. B.E. Jaski, M.L. Jessup, D.M. Mancini, T.P. Cappola, D.F. Pauly, B. Greenberg, K. Borow, H. Dittrich, K.M. Zsebo, and R.J. Hajjar Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial J. Card. Fail. 15 2009 171 181
45. 2+ -ATPase and calcium homeostasis in cardiac myocytes Lab. Invest. 91 2011 1291 1297
46. H.S. Karagueuzian, M. Ohta, J.K. Drury, M.C. Fishbein, S. Meerbaum, E. Corday, W.J. Mandel, and T. Peter Coronary venous retroinfusion of procainamide: a new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarction J. Am. Coll. Cardiol. 7 1986 551 563
47. D.M. Kaye, A. Preovolos, T. Marshall, M. Byrne, M. Hoshijima, R. Hajjar, J.A. Mariani, S. Pepe, K.R. Chien, and J.M. Power Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals J. Am. Coll. Cardiol. 50 2007 253 260
48. H. Khan, M. Metra, J.E. Blair, M. Vogel, M.E. Harinstein, G.S. Filippatos, H.N. Sabbah, H. Porchet, G. Valentini, and M. Gheorghiade Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes? Heart Fail. Rev. 14 2009 277 287
49. S.J. Kim, M. Abdellatif, S. Koul, and G.J. Crystal Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway Am. J. Physiol. Heart Circ. Physiol. 295 2008 H130 135
50. 2+-ATPase 2 gene transcription through modification of Sp1 binding Biochem. Biophys. Res. Commun. 328 2005 116 124
51. E.G. Kranias, and R.J. Hajjar Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome Circ. Res. 110 2012 1646 1660
52. H. Kubo, K.B. Margulies, V. Piacentino 3rd, J.P. Gaughan, and S.R. Houser Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance Circulation 104 2001 1012 1018
53. J.M. Lamers, and J.T. Stinis Defective calcium pump in the sarcoplasmic reticulum of the hypertrophied rabbit heart Life Sci. 24 1979 2313 2319
54. 2+ uptake by sarcoplasmic reticulum after coronary artery occlusion for 60 and 90 min Circ. Res. 21 1967 439 444
55. C.J. Limas, M.T. Olivari, I.F. Goldenberg, T.B. Levine, D.G. Benditt, and A. Simon Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy Cardiovasc. Res. 21 1987 601 605
56. A.M. Lompre, M. Anger, and D. Levitsky Sarco(endo)plasmic reticulum calcium pumps in the cardiovascular system: function and gene expression J. Mol. Cell. Cardiol. 26 1994 1109 1121
57. 2+-ATPase gene J. Biol. Chem. 263 1988 15024 15031
58. J. Lytton, M. Westlin, S.E. Burk, G.E. Shull, and D.H. MacLennan Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps J. Biol. Chem. 267 1992 14483 14489
59. 2+ ATPase of sarcoplasmic reticulum Acta Physiol. Scand. Suppl. 607 1992 141 150
60. 2+ handling in the post-infarction rat heart Cardiovasc. Res. 79 2008 42 51
61. M. Meyer, W. Schillinger, B. Pieske, C. Holubarsch, C. Heilmann, H. Posival, G. Kuwajima, K. Mikoshiba, H. Just, and G. Hasenfuss et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy Circulation 92 1995 778 784
62. R. Micheletti, F. Palazzo, P. Barassi, G. Giacalone, M. Ferrandi, A. Schiavone, B. Moro, O. Parodi, P. Ferrari, and G. Bianchi Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure Am. J. Cardiol. 99 2007 24A 32A
63. 2+-ATPase J. Biol. Chem. 273 1998 12360 12369
64. J.M. Pearl, D.M. Plank, K.M. McLean, C.J. Wagner, and J.Y. Duffy Glucocorticoids improve calcium cycling in cardiac myocytes after cardiopulmonary bypass J. Surg. Res. 167 2011 279 286
65. 2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology Cardiovasc. Res. 77 2008 265 273
66. M. Periasamy, and S. Huke SERCA pump level is a critical determinant of Ca(2+)homeostasis and cardiac contractility J. Mol. Cell. Cardiol. 33 2001 1053 1063
67. 2+-ATPase isoform 2 (SERCA2) gene J. Biol. Chem. 274 1999 2556 2562
68. 2+ exchange molecule: an overview Ann. N. Y. Acad. Sci. 976 2002 1 10
69. 2+-ATPases by cyclopiazonic acid J. Biol. Chem. 272 1997 2794 2800
70. A.M. Prasad, and G. Inesi Silencing calcineurin A subunit reduces SERCA2 expression in cardiac myocytes Am. J. Physiol. Heart Circ. Physiol. 300 2011 H173 180
71. U. Rasmussen, S. Broogger Christensen, and F. Sandberg Thapsigargine and thapsigargicine, two new histamine liberators from Thapsia garganica L Acta Pharm. Suec. 15 1978 133 140
72. H. Rupp, and R. Vetter Sarcoplasmic reticulum function and carnitine palmitoyltransferase-1 inhibition during progression of heart failure Br. J. Pharmacol. 131 2000 1748 1756
73. 2+-ATPase protein and activity Am. J. Physiol. Heart Circ. Physiol. 294 2008 H2587 2595
74. L. Ryden, H. Tadokoro, P.O. Sjoquist, C. Regardh, S. Kobayashi, E. Corday, and J.K. Drury Pharmacokinetic analysis of coronary venous retroinfusion: a comparison with anterograde coronary artery drug administration using metoprolol as a tracer J. Am. Coll. Cardiol. 18 1991 603 612
75. V.A. Schroeder, J.M. Pearl, S.M. Schwartz, T.P. Shanley, P.B. Manning, and D.P. Nelson Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression Circulation 107 2003 2823 2828
76. J. Schultz Jel, B.J. Glascock, S.A. Witt, M.L. Nieman, K.J. Nattamai, L.H. Liu, J.N. Lorenz, G.E. Shull, T.R. Kimball, and M. Periasamy Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity Am. J. Physiol. Heart Circ. Physiol. 286 2004 H1146 1153
77. 2+-ATPase of sarcoplasmic reticulum J. Biol. Chem. 264 1989 17816 17823
78. M. Shibata, D. Takeshita, K. Obata, S. Mitsuyama, H. Ito, G.X. Zhang, and M. Takaki NHE-1 participates in isoproterenol-induced downregulation of SERCA2a and development of cardiac remodeling in rat hearts Am. J. Physiol. Heart Circ. Physiol. 301 2011 H2154 2160
79. 2+-transporting ATPases Eur. J. Biochem. 267 2000 5284 5290
80. H.K. Simmerman, and L.R. Jones Phospholamban: protein structure, mechanism of action, and role in cardiac function Physiol. Rev. 78 1998 921 947
81. M. Soga, F.A. Kamal, K. Watanabe, M. Ma, S. Palaniyandi, P. Prakash, P. Veeraveedu, S. Mito, M. Kunisaki, H. Tachikawa, M. Kodama, and Y. Aizawa Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats Int. J. Cardiol. 110 2006 378 385
82. M. Sulaiman, M.J. Matta, N.R. Sunderesan, M.P. Gupta, M. Periasamy, and M. Gupta Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy Am. J. Physiol. Heart Circ. Physiol. 298 2010 H833 843
83. Y.L. Sun, S.J. Hu, L.H. Wang, Y. Hu, and J.Y. Zhou Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats Chest 128 2005 1812 1821
84. D. Takeshita, J. Shimizu, Y. Kitagawa, D. Yamashita, K. Tohne, C. Nakajima-Takenaka, H. Ito, and M. Takaki Isoproterenol-induced hypertrophied rat hearts: does short-term treatment correspond to long-term treatment? J. Physiol. Sci. 58 2008 179 188
85. M.A. Talukder, J.L. Zweier, and M. Periasamy Targeting calcium transport in ischaemic heart disease Cardiovasc. Res. 84 2009 345 352
86. L. Tilemann, K. Ishikawa, T. Weber, and R.J. Hajjar Gene therapy for heart failure Circ. Res. 110 2012 777 793
87. K. Toba, T. Katagiri, and Y. Takeyama Studies of the cardiac sarcoplasmic reticulum in myocardial infarction Jpn. Circ. J. 42 1978 447 453
88. L.S. Tobacman Thin filament-mediated regulation of cardiac contraction Annu. Rev. Physiol. 58 1996 447 481
89. 2+-ATPase 2 gene transcript Biochem. J. 322 Pt 3 1997 885 891
90. 2+ pump Proc. Natl. Acad. Sci. USA 106 2009 18533 18538
91. 2+ ATPase 2 (SERCA2) activity: cell biological implications Cell Calcium 38 2005 291 302
92. 2+ affinity in cardiac function Biochim. Biophys. Acta 1763 2006 1216 1228
93. M. Ver Heyen, S. Heymans, G. Antoons, T. Reed, M. Periasamy, B. Awede, J. Lebacq, P. Vangheluwe, M. Dewerchin, D. Collen, K. Sipido, P. Carmeliet, and F. Wuytack Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart Circ. Res. 89 2001 838 846
94. H. Verboomen, F. Wuytack, L. Van den Bosch, L. Mertens, and R. Casteels The functional importance of the extreme C-terminal tail in the gene 2 organellar Ca(2+)-transport ATPase (SERCA2a/b) Biochem. J. 303 Pt 3 1994 979 984
95. T. Wang, L.I. Tsai, and A. Schwartz Effects of verapamil, diltiazem, nisoldipine and felodipine on sarcoplasmic reticulum Eur. J. Pharmacol. 100 1984 253 261
96. F. Wuytack, L. Raeymaekers, and L. Missiaen Molecular physiology of the SERCA and SPCA pumps Cell Calcium 32 2002 279 305
97. F. Wuytack, L. van den Bosch, M. Ver Heyen, F. Baba-Aissa, L. Raeymaekers, and R. Casteels Regulation of alternative splicing of the SERCA2 pre-mRNA in muscle Ann. N. Y. Acad. Sci. 853 1998 372 375
98. X.L. Xu, X.J. Chen, H. Ji, P. Li, Y.Y. Bian, D. Yang, J.D. Xu, Z.P. Bian, and J.N. Zhang Astragaloside IV improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca-ATPase Pharmacology 81 2008 325 332
99. A. Yao, Z. Su, W.H. Dillmann, and W.H. Barry Sarcoplasmic reticulum function in murine ventricular myocytes overexpressing SR CaATPase J. Mol. Cell. Cardiol. 30 1998 2711 2718
100. A.V. Zima, J. Qin, M. Fill, and L.A. Blatter Tricyclic antidepressant amitriptyline alters sarcoplasmic reticulum calcium handling in ventricular myocytes Am. J. Physiol. Heart Circ. Physiol. 295 2008 H2008 2016
101. C. Zincarelli, S. Soltys, G. Rengo, and J.E. Rabinowitz Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection Mol. Ther. 16 2008 1073 1080
102. Zsebo, A., Yaroshinsky, A., Rudy, J., Wagner, K., Jessup, M., Greenberg, B., Hajjar, R., 2013. Long Term Follow-up of Patients With Advanced Heart Failure Following a Single Intracoronary Infusion of AAV1/SERCA2a. AHA Dallas 2013 Abstract Presentation.
103. R. Zucchi, S. Ronca-Testoni, P. Di Napoli, G. Yu, S. Gallina, G. Bosco, G. Ronca, A.M. Calafiore, M. Mariani, and A. Barsotti Sarcoplasmic reticulum calcium uptake in human myocardium subjected to ischemia and reperfusion during cardiac surgery J. Mol. Cell. Cardiol. 28 1996 1693 1701